loadpatents
name:-0.0085239410400391
name:-0.0066661834716797
name:-0.0014858245849609
LEON MONZON; Kalet Patent Filings

LEON MONZON; Kalet

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEON MONZON; Kalet.The latest application filed is for "method for expansion and differentiation of t lymphocytes and nk cells for adoptive transfer therapies".

Company Profile
1.6.8
  • LEON MONZON; Kalet - La Habana CU
  • LEON MONZON; Kalet - Havana CU
  • Leon Monzon; Kalet - La Lisa CU
  • Leon Monzon; Kalet - Ciudad de la Habana N/A CU
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method For Expansion And Differentiation Of T Lymphocytes And Nk Cells For Adoptive Transfer Therapies
App 20220152107 - LEON MONZON; Kalet ;   et al.
2022-05-19
Fusion Proteins Composed of an Interleukin-2 Mutein and Type I Interferon
App 20210238246 - HERN NDEZ GARCiA; Tays ;   et al.
2021-08-05
Antibodies with Increased Affinity for the Epidermal Growth Factor Receptor and Fragments Derived Therefrom
App 20210002375 - Tundidor Cabado; Yaima ;   et al.
2021-01-07
Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)
Grant 9,790,279 - Gonzalez Palomo , et al. October 17, 2
2017-10-17
TGF.beta.-derived polypeptides and uses thereof
Grant 9,701,730 - Corria Osorio , et al. July 11, 2
2017-07-11
IL-2 derivative polypeptides
Grant 9,206,243 - Leon Monzon , et al. December 8, 2
2015-12-08
TGFBeta-derived polypeptides and uses thereof
App 20150284441 - Corria Osorio; ngel de Jes s ;   et al.
2015-10-08
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMORS EXPRESSING EGFR AND GM3 N-GLYCOLYL GANGLIOSIDE (NeuGcGM3)
App 20140363494 - Gonzalez Palomo; Adys ;   et al.
2014-12-11
Il-2 Derivatives Polypeptides With Agonist Activity For Therapy Of Cancer And Chronic Infections
App 20140314709 - Leon Monzon; Kalet ;   et al.
2014-10-23
Immunomodulatory interleukin-2 polypeptides and methods of treating melanoma
Grant 8,759,486 - Leon Monzon , et al. June 24, 2
2014-06-24
Immunomodulator Polypeptides Derived From Il-2 And Their Use Thereof In The Therapeutic Of Cancer And Chronic Infections
App 20120315245 - Leon Monzon; Kalet ;   et al.
2012-12-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed